HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)

Clinical trial NCT06978296 · RECRUITING

Trial details

NCT number: NCT06978296
Sponsor: Institut Cancerologie de l'Ouest
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Disease Oligometastatic Prostate Cancer (OMPC)

Start date: 2026-06-01
Primary completion: 2028-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.